British American Tobacco's chief operating officer John Daly has invested nearly £511,000 in shares in the tobacco company.
He has bought 21,200 shares at 2408.57p each and that takes his beneficial stake to 52,417 shares.
Daly joined BAT as a result of its merger with Rothmans in 1999. He was appointed as chief operating officer of the group in September at the same time that Nicandro Durante took on the role of chief executive designate. Durante takes over as chief executive next February. Daly was previously regional director for Asia Pacific.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In July, BAT said that it expects another year of good growth in both earnings and dividends. Pre-tax profit rose to £2,279m in the six months to 30 June, up from £2,123m in the first half of 2009.
The tobacco firm increased its interim dividend from 27.9p a share to 33.2p a share.
Top Director Buys
British American Tobacco (BATS) Director name: Mr John DalyAmount purchased: 21,200 @ 2,408.57p Value: £510,617
PSG Solutions (PGS) Director name: Mr Bernard Cavan ConnorAmount purchased: 300,000 @ 24.00p Value: £72,000
GlaxoSmithKline (GSK) Director name: Dr Dr Dan PodolskyAmount purchased: 2,078 @ 1,265.19p Value: £26,291
GlaxoSmithKline (GSK) Director name: Sir Christopher GentAmount purchased: 2,685 @ 1,257.00p Value: £33,750
Ascent Resources (AST) Director name: Mr Jeremy EngAmount purchased: 699,815 @ 4.38p Value: £30,652
GlaxoSmithKline (GSK) Director name: Mr Lawrence CulpAmount purchased: 1,539 @ 1,265.19p Value: £19,471
Cyan (CYAN) Director name: Dr John ReadAmount purchased: 3,088,221 @ 0.90p Value: £27,794
Cyan (CYAN) Director name: Mr Simon Smith Amount purchased: 2,777,778 @ 0.90p Value: £25,000
GlaxoSmithKline (GSK) Director name: Sir Sir Crispin H L DavisAmount purchased: 1,889 @ 1,257.00p Value: £23,745
Unilever (ULVR) Director name: Ms Ann M FudgeAmount purchased: 700 @ 1,849.80p Value: £12,949
Top Director Sells
Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 179.78p Value: £359,560
Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 178.26p Value: £356,520
BrainJuicer Group (BJU) Director name: Mr James GeddesAmount sold: 125,000 @ 200.00p Value: £250,000
Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 100,000 @ 177.91p Value: £177,910
Red Rock Resources (RRR) Director name: Mr Andrew Ronald McMillan BellAmount sold: 1,000,000 @ 6.09p Value: £60,900
-
-
Savers will benefit from Plum’s 4.94% money market account
Savers will benefit from Plum's 4.94% product that relies on money market funds that closely track the Bank of England’s base rate. We explain why this could be good news for savers.
-
Revealed: Best funds for DIY investors
Wondering where to put your money? With thousands of investment options, which funds, ETFs, trusts are the best? Bestinvest has just released it’s best funds list - we have all the details to help you strengthen your portfolio
